Showing results (1-10 of 129) with videos related to
Sort By:
Pageof 13
Molecular & Cellular Oncology|August 19, 2017
Connecting androgen receptor signaling and the DNA damage response: Development of new therapies for advanced prostate cancerTimothy C Thompson, Likun LiAsian Journal of Urology|March 8, 2018
Novel anti-androgen receptor signaling agents: Understanding the mechanisms of resistanceStyliani Karanika, Theodoros Karantanos, Jianhua Yin, et al.Genomics|May 23, 2006
Identification and characterization of RTVP1/GLIPR1-like genes, a novel p53 target gene clusterChengzhen Ren, Cheng-Hui Ren, Likun Li, et al.Molecular and Cellular Biology|December 4, 2003
Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2ALikun Li, Cheng Hui Ren, Salahaldin A Tahir, et al.Molecular Cancer Research : MCR|November 12, 2009
Caveolin-1 promotes autoregulatory, Akt-mediated induction of cancer-promoting growth factors in prostate cancer cellsLikun Li, Chengzhen Ren, Guang Yang, et al.Current Medicinal Chemistry|December 17, 2016
Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future DirectionsSpyridon P Basourakos, Likun Li, Ana M Aparicio, et al.Cancer Cell|June 15, 2010
Grappling with the androgen receptor: a new approach for treating advanced prostate cancerTimothy C ThompsonCancer Cell|November 13, 2007
Suppression of tumor suppressors in prostate cancer: the emergence of a novel oncogenic pathwayTimothy C ThompsonCancer Cell|June 14, 2011
Turning reciprocal feedback regulation into combination therapyTimothy C ThompsonYonsei Medical Journal|May 26, 2010
Glioma pathogenesis-related protein 1: tumor-suppressor activities and therapeutic potentialTimothy C ThompsonPageof 13